| Catalog Number |
07K65-34 |
| Medical Device Problem Code |
High Test Results (2457)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
07/05/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Complete entry for section a1 - patient identifier: (b)(6).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.
|
| |
|
Event or Problem Description
|
|
The customer observed a falsely elevated architect free t4 for one patient.The following results were provided: sid: (b)(6) , initial test > 5.0 ng/dl; repeat result= 2.41 ng/dl.Additional information was provided: tsh= 1.066 uiu/ml; tsh 1:5 dilution= 1.371 uiu/ml; ft3= 1.81 pg/ml.There was no impact to patient management reported.
|
| |
|
Event or Problem Description
|
|
The customer observed a falsely elevated architect free t4 for one patient.The following results were provided: sid: (b)(6), initial test > 5.0 ng/dl; repeat result= 2.41 ng/dl.Additional information was provided: tsh= 1.066 uiu/ml; tsh 1:5 dilution= 1.371 uiu/ml; ft3= 1.81 pg/ml.There was no impact to patient management reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Return testing was not completed as returns were not available.Data and information provided by the customer were reviewed and support the complaint issue.An increase in complaints has been observed for lot 57269ud00, however, in-house performance testing was completed which indicates the product is performing as expected.Device history record review did not identify any non-conformances, potential non-conformances, or deviations associated with lot 57269ud00 and the complaint issue.Labeling was reviewed and sufficiently addresses the customer¿s issue.Based on our investigation, no systemic issue or deficiency with the architect free t4 for reagent for lot 57269ud00 was identified.
|
| |
|
Search Alerts/Recalls
|